Cardiometabolic Disorders

Top Story

NASH linked to early markers of hypertrophy

July 26, 2017

A retrospective study revealed a link between nonalcoholic steatohepatitis and changes in myocardial structure as well as increased left atrial volume and left ventricular mass.

“We found that NASH was strongly associated with markers of diastolic dysfunction and also with ventricular wall thickening, indicative of early hypertrophy,” Tracey G. Simon, MD, from the Massachusetts General Hospital and Harvard Medical School, Boston, and colleagues wrote. “Such findings carry important clinical implications, as diastolic dysfunction is a well-described predictor of future [heart failure] risk within the general population.”

In the Journals Plus

Late-night salivary cortisol accurate test for Cushing's syndrome in obesity, PCOS

July 26, 2017
Measuring late-night salivary cortisol levels was an accurate method for diagnosing Cushing’s syndrome among women with polycystic ovary syndrome or obesity…
Meeting News

Different approach to CVD risk assessment should be taken in patients with diabetes

July 26, 2017
PHILADELPHIA — Models to assess CV risk in patients with diabetes often underestimate risk, but the addition of clinical tests including imaging tests and…
In the Journals

Hormone therapy for transgender adults poses potential CVD risks

July 25, 2017
Long-term cross-sex hormone therapy for transgender individuals is associated with potential cardiovascular risks, but also offers psychological benefits, according to a…
More Headlines »
CME

Practical Lipidology®: Volume 3, Number 2

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News

VIDEO: Glycemic control key to avoid CV complications in diabetes

July 14, 2017
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

CME

Practical Lipidology®: Volume 3, Number 1

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Advertisement
Advertisement